Polymarket Market
Prediction market
Track current outcome prices, market depth, volume, liquidity, and recent trades for Prediction market.
Upcoming
- Probability
- 3.8%
- Liquidity
- $59.49K
- Best bid
- 0.1%
- Best ask
- 99.9%
- Spread
- 99.8%
- Last trade
- 3.8%
Outcomes
Market outcomes
Live pricing
Pricing and liquidity
Current bid, ask, midpoint, spread, and market depth for this outcome.
- Best bid
- 0.1%
- Best ask
- 99.9%
- Midpoint
- 50%
- Spread
- 99.8%
- Last trade
- 3.8%
- Depth
- 10,951.16 / 48,534.02
Price history
Waiting for price history
History unavailable
Bids
| Price | Size |
|---|---|
| 0.1% | 6,195 |
| 0.2% | 211 |
| 0.9% | 444.44 |
| 1.3% | 550 |
| 2% | 1,200 |
| 2.4% | 50 |
| 2.9% | 1,200 |
| 3% | 755.72 |
Asks
| Price | Size |
|---|---|
| 99.9% | 180.16 |
| 99.8% | 25 |
| 99.7% | 10,000 |
| 99.6% | 6.65 |
| 99% | 18,000 |
| 98.9% | 58.56 |
| 90% | 2,721 |
| 88.3% | 900 |
Trades
Recent trades
Latest visible trades for this market.
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.8B?Yes 3.8% 13 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.8B?Yes 3.8% 13.31 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.8B?Yes 1.4% 13.31 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.8B?Yes 1.7% 100 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.8B?No 87.4% 50 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.8B?No 95.3% 412.64 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.8B?No 98% 134.8 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.8B?Yes 4% 13.27 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.8B?Yes 4% 53.73 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.8B?Yes 5% 19.6 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.8B?Yes 5% 10 shares
- Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above $16.8B?Yes 6% 6.69 shares